16 results match your criteria: "Center for Medication Use[Affiliation]"
JAMA Netw Open
July 2024
Department of Pharmacy, School of Pharmacy, University of Washington, Seattle.
Importance: High-risk medications that contribute to adverse health outcomes are frequently prescribed to older adults. Deprescribing interventions reduce their use, but studies are often not designed to examine effects on patient-relevant health outcomes.
Objective: To test the effect of a health system-embedded deprescribing intervention targeting older adults and their primary care clinicians for reducing the use of central nervous system-active drugs and preventing medically treated falls.
Indian J Pharm Sci
September 2010
Center for Medication Use, Policy, and Economics, The University of Michigan, College of Pharmacy, 428 Church Street, Ann Arbor, MI, 48109-1065, USA.
Medical mistakes that include medication errors have raised concerns about medication safety. Due to high consumption of medicines and self-treatment by all, especially the aging population, the issue of proper medication use and safety is at the forefront of public health concerns globally. Each country has a different approach towards medication event monitoring that is compliant with its own health care system.
View Article and Find Full Text PDFJ Prim Care Community Health
April 2011
Department of Clinical, Social and Administrative Sciences, CMUPE-Center for Medication Use, Policy and Economics, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
Background: As stated by Donabedian, the father of quality assurance, satisfaction is an integral component of quality in medical care. Patient satisfaction is an important predictor of health-related behaviors, use of medical services, and health outcomes. Impressive literature exists in examining various aspects of patient satisfaction, however, no study thus far has examined differences in patient satisfaction between first and return visits to primary care physicians.
View Article and Find Full Text PDFJ Stroke Cerebrovasc Dis
April 2011
Department of Internal Medicine, College of Medicine, and Division of Health Services Management & Policy, College of Public Health, Ohio State University, Columbus, Ohio (former institution); Ann Arbor VA Healthcare System, Departments of Medicine and Neurology, University of Michigan, Ann Arbor, Michigan (current institution). Electronic address:
Emergency department waiting time (EDWT), the time from arrival at the ED to evaluation by an emergency physician, is a critical component of acute stroke care. We assessed racial/ethnic differences in EDWT in a national sample of patients with ischemic or hemorrhagic stroke. We identified 543 ED visits for ischemic stroke (International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM] codes 433.
View Article and Find Full Text PDFExpert Opin Biol Ther
January 2010
The University of Michigan, Center for Medication Use, Policy and Economics, Ann Arbor, Michigan 48109-1065, USA.
Importance Of The Field: Psoriasis is an immune-mediated skin condition affecting 2 - 3% of world's population. It affects patients' health-related quality of life (HRQOL) and results in a significant financial burden. Adalimumab is the first fully human monoclonal antibody approved in the US and European countries for the treatment of psoriasis along with other immunomediated diseases.
View Article and Find Full Text PDFJ Dermatolog Treat
May 2010
Center for Medication Use, Policy, and Economics, University of Michigan, Ann Arbor, Michigan 48109-1065, USA.
Objective: To examine the prescribing patterns of topical retinoids in the United States.
Methods: A retrospective, cross-sectional study was employed. Data from the National Ambulatory Medical Care Survey (1990-2004) were used.
J Dermatolog Treat
May 2010
Center for Medication Use, Policy, and Economics, University of Michigan, Ann Arbor, MI 48109-1065, USA.
Objective: The introduction of novel therapeutic options for psoriasis has raised managed care's interest in controlling costs associated with dermatological treatments. Prior authorization (PA) can be a successful way of managing costs. However, experience with topical treatments for acne suggests that PA may not be cost-effective.
View Article and Find Full Text PDFJ Am Pharm Assoc (2003)
April 2008
College of Pharmacy, University of Michigan, Ann Arbor.
Objective: To describe the development, implementation, and evaluation of a pharmacist patient care program for persons taking multiple medications for chronic diseases.
Design: Pilot study.
Setting: Services were provided in Michigan within community pharmacies and through home and work-site visits, between October 2004 and September 2006.
Am J Health Syst Pharm
October 2007
Center for Medication Use, Policy, and Economics, College of Pharmacy, University of Michigan (UM), Ann Arbor, MI 48109-1065, USA.
Purpose: The effect of pharmacy practice residency training on subjectively and objectively assessed research knowledge, skills, and interests of residents was studied.
Methods: A preintervention versus post-intervention design was used. Residency year 2004- 05 residents were administered a validated Web-based survey at the beginning of residency and again at the end of residency.
Med Care Res Rev
August 2006
University of Michigan, College of Pharmacy, Center for Medication Use, Policy, and Economics, Ann Arbor, MI 48109-1065, USA.
Nine national surveys documenting patient underuse of prescription medications were examined to describe the variation and trends in that underuse and identify possible reasons for the substantially different rates that were reported. Underuse includes unfilled prescriptions, delayed therapy, reduced frequency, and lowered dosage. Rates of cost-related patient underuse in the studies ranged from 1.
View Article and Find Full Text PDFAm J Manag Care
February 2005
Center for Medication Use, Policy and Economics, Department of Social and Administrative Sciences, University of Michigan College of Pharmacy, 428 Church Street, Ann Arbor, MI 48109-1065, USA.
Objective: To determine whether there were sex-related differences in the management of dyslipidemia among managed care enrollees with diabetes mellitus.
Study Design And Methods: Retrospective analyses were conducted using medical and pharmacy claims data from a health maintenance organization during 2000 and 2001. Patients with type 2 diabetes mellitus were identified through a validated algorithm of medication and diagnosis codes.
Am J Manag Care
February 2004
Center for Medication Use, Policy and Economics, Department of Social and Administrative Sciences, University of Michigan College of Pharmacy, Ann Arbor, Mich 48109-1065, USA.
Objectives: To identify trends in the utilization of multidrug therapy for glycemic control, angiotensin-converting enzyme inhibitors/angiotensin receptor blockers (ACEIs/ARBs), and lipid-modifying agents for persons with diabetes from 1997 to 2001. The trends in drug and total expenditures for diabetes patients also were examined.
Study Design: Cross-sectional analysis for each year from 1997 through 2001.
Am J Health Syst Pharm
January 2004
Center for Medication Use, Policy, and Economics, Department of Social and Administrative Sciences, College of Pharmacy, University of Michigan (UM), 428 Church Street, Ann Arbor, MI 48109-1065, USA.
Purpose: The relationship between hospital size and quality improvement (QI) for pharmaceutical services was studied.
Methods: A questionnaire on QI was sent to hospital pharmacy directors in Michigan and Florida in 2002. The questionnaire included items on QI lead-team composition, QI tools, QI training, and QI culture.
J Manag Care Pharm
January 2004
Department of Social and Administrative Sciences, Center for Medication Use, Policy and Economics, University of Michigan College of Pharmacy, Ann Arbor, USA.
Ann Pharmacother
November 2002
Center for Medication Use, Policy & Economics, University of Michigan, Ann Arbor, USA.
Clin Ther
June 2002
Center for Medication Use, Policy & Economics, University of Michigan, Ann Arbor 48109-1065, USA.
Background: Affordability may be defined as the absence of economic barriers to a good or service. There are 2 frequently observed measures of affordability: a consumer's ability to pay and his or her physical access to a good or service. Thus, most programs designed to subsidize consumers' health care costs, especially state programs that address prescription drug expenditures for people aged > or =65 years, base eligibility on measures of income as a proxy for a consumer's ability to pay.
View Article and Find Full Text PDF